Hematology Drugs Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：125頁
文件格式：PDF
價 格：
USD 4,000 (Single-User License)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, conditions related to sickle cell disease, and other related diseases.
The global hematology drugs market was estimated to be around $37 billion as of 2016. The hematology drugs market made up around 3.5% of the overall pharmaceuticals market in 2016. The hematology drugs market was the twelfth largest market in the global pharmaceutical market in 2016.
Product Approvals
Increase in number of hematology disease drug approvals from the regulatory bodies such as FDA in the US and EMA in EU is an emerging trend in the market. For instance, in June 2017, Novo Nordisk received FDA approval for its Rebinyn (Coagulation Factor IX (Recombinant), GlycoPEGylated) that is used in the treatment of hemophilia B. In April 2017, Novartis received FDA approval for its Rydapt (midostaurin) drug that is used in the treatment of positive acute myeloid leukemia and mastocytosis.
The global hematology drugs market was estimated to be around $37 billion as of 2016. The hematology drugs market made up around 3.5% of the overall pharmaceuticals market in 2016. The hematology drugs market was the twelfth largest market in the global pharmaceutical market in 2016.
Product Approvals
Increase in number of hematology disease drug approvals from the regulatory bodies such as FDA in the US and EMA in EU is an emerging trend in the market. For instance, in June 2017, Novo Nordisk received FDA approval for its Rebinyn (Coagulation Factor IX (Recombinant), GlycoPEGylated) that is used in the treatment of hemophilia B. In April 2017, Novartis received FDA approval for its Rydapt (midostaurin) drug that is used in the treatment of positive acute myeloid leukemia and mastocytosis.
1. Hematology Drugs Market Characteristics;
2. Hematology Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Hematology Drugs Market Customer Information;
5. Hematology Drugs Market Segmentation;
5.1. Global Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 5.2. Global Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Hematology Drugs Market Trends And Strategies;
6. Hematology Drugs Market Regional And Country Analysis;
6.1. Global Hematology Drugs Market, 2016, By Region; 6.2. Global Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Hematology Drugs Market, 2016, By Country; 6.4. Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;
7. Global Hematology Drugs Market Comparison With Macro Economic Factors;
7.1. Hematology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Hematology Drugs Expenditure, Global;
8. Hematology Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Hematology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Hematology Drugs Expenditure, By Country;
9. Hematology Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Hematology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Hematology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Hematology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Hematology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Thalassemia, 2014, By Country;
10. Asia-Pacific Hematology Drugs Market;
10.1.1. Asia-Pacific Hematology Drugs Market Overview; 10.1.2. Asia-Pacific Hematology Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Hematology Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.2. Asia-Pacific Hematology Drugs Market: Country Analysis; 10.3. China Hematology Drugs Market; 10.3.1. China Hematology Drugs Market Overview; 10.3.2. China Hematology Drugs Historic Market, 2012 - 2016; 10.3.3. China Hematology Drugs Forecast Market, 2016 - 2020; 10.3.4. China Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.3.5. China Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.4. India Hematology Drugs Market; 10.4.1. India Hematology Drugs Market Overview; 10.4.2. India Hematology Drugs Historic Market, 2012 - 2016; 10.4.3. India Hematology Drugs Forecast Market, 2016 - 2020; 10.4.4. India Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.4.5. India Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.5. Japan Hematology Drugs Market; 10.5.1. Japan Hematology Drugs Market Overview; 10.5.2. Japan Hematology Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Hematology Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.5.5. Japan Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.6. Australia Hematology Drugs Market; 10.6.1. Australia Hematology Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Hematology Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.6.4. Australia Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
11. Western Europe Hematology Drugs Market;
11.1.1. Western Europe Hematology Drugs Market Overview; 11.1.2. Western Europe Hematology Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Hematology Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.2. Western Europe Hematology Drugs Market: Country Analysis; 11.3. UK Hematology Drugs Market; 11.3.1. UK Hematology Drugs Market Overview; 11.3.2. UK Hematology Drugs Historic Market, 2012 - 2016; 11.3.3. UK Hematology Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.3.5. UK Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.4. Germany Hematology Drugs Market; 11.4.1. Germany Hematology Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Hematology Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.4.4 Germany Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.5 France Hematology Drugs Market; 11.5.1 France Hematology Drugs Historic Market, 2012 - 2016; 11.5.2 France Hematology Drugs Forecast Market, 2016 - 2020; 11.5.3 France Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.5.4 France Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.6. Italy Hematology Drugs Market; 11.6.1. Italy Hematology Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Hematology Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.6.4. Italy Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.7. Spain Hematology Drugs Market; 11.7.1. Spain Hematology Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Hematology Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.7.4. Spain Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Hematology Drugs Market;
12.1.1. Eastern Europe Hematology Drugs Market Overview; 12.1.2. Eastern Europe Hematology Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Hematology Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 12.2. Eastern Europe Hematology Drugs Market: Country Analysis; 12.3. Russia Hematology Drugs Market; 12.3.1. Russia Hematology Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Hematology Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 12.3.4. Russia Hematology Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
13. North America Hematology Drugs Market;
13.1.1. North America Hematology Drugs Market Overview; 13.1.2. North America Hematology Drugs Historic Market, 2012 - 2016; 13.1.3. North America Hematology Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 13.2. North America Hematology Drugs Market: Country Analysis; 13.3. USA Hematology Drugs Market; 13.3.1. USA Hematology Drugs Historic Market, 2012 - 2016; 13.3.2. USA Hematology Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 13.3.4. USA Hematology Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
14. South America Hematology Drugs Market;
14.1.1. South America Hematology Drugs Market Overview; 14.1.2. South America Hematology Drugs Historic Market, 2012 - 2016; 14.1.3. South America Hematology Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 14.2. South America Hematology Drugs Market: Country Analysis; 14.3. Brazil Hematology Drugs Market; 14.3. Brazil Hematology Drugs Market; 14.3.1. Brazil Hematology Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Hematology Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 14.3.4. Brazil Hematology Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
15. Middle East Hematology Drugs Market;
15.1.1. Middle East Hematology Drugs Market Overview; 15.1.2. Middle East Hematology Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Hematology Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs;
16. Africa Hematology Drugs Market;
16.1.1. Africa Hematology Drugs Market Overview; 16.1.2. Africa Hematology Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Hematology Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs;
17. Hematology Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Baxalta; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Bayer Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Novo Nordisk; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Biogen Idec; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Hematology Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Hematology Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Hematology Drugs Market Customer Information;
5. Hematology Drugs Market Segmentation;
5.1. Global Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 5.2. Global Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Hematology Drugs Market Trends And Strategies;
6. Hematology Drugs Market Regional And Country Analysis;
6.1. Global Hematology Drugs Market, 2016, By Region; 6.2. Global Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Hematology Drugs Market, 2016, By Country; 6.4. Hematology Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;
7. Global Hematology Drugs Market Comparison With Macro Economic Factors;
7.1. Hematology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Hematology Drugs Expenditure, Global;
8. Hematology Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Hematology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Hematology Drugs Expenditure, By Country;
9. Hematology Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Hematology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Hematology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Hematology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Hematology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Thalassemia, 2014, By Country;
10. Asia-Pacific Hematology Drugs Market;
10.1.1. Asia-Pacific Hematology Drugs Market Overview; 10.1.2. Asia-Pacific Hematology Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Hematology Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.2. Asia-Pacific Hematology Drugs Market: Country Analysis; 10.3. China Hematology Drugs Market; 10.3.1. China Hematology Drugs Market Overview; 10.3.2. China Hematology Drugs Historic Market, 2012 - 2016; 10.3.3. China Hematology Drugs Forecast Market, 2016 - 2020; 10.3.4. China Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.3.5. China Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.4. India Hematology Drugs Market; 10.4.1. India Hematology Drugs Market Overview; 10.4.2. India Hematology Drugs Historic Market, 2012 - 2016; 10.4.3. India Hematology Drugs Forecast Market, 2016 - 2020; 10.4.4. India Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.4.5. India Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.5. Japan Hematology Drugs Market; 10.5.1. Japan Hematology Drugs Market Overview; 10.5.2. Japan Hematology Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Hematology Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.5.5. Japan Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 10.6. Australia Hematology Drugs Market; 10.6.1. Australia Hematology Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Hematology Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 10.6.4. Australia Hematology Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
11. Western Europe Hematology Drugs Market;
11.1.1. Western Europe Hematology Drugs Market Overview; 11.1.2. Western Europe Hematology Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Hematology Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.2. Western Europe Hematology Drugs Market: Country Analysis; 11.3. UK Hematology Drugs Market; 11.3.1. UK Hematology Drugs Market Overview; 11.3.2. UK Hematology Drugs Historic Market, 2012 - 2016; 11.3.3. UK Hematology Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.3.5. UK Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.4. Germany Hematology Drugs Market; 11.4.1. Germany Hematology Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Hematology Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.4.4 Germany Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.5 France Hematology Drugs Market; 11.5.1 France Hematology Drugs Historic Market, 2012 - 2016; 11.5.2 France Hematology Drugs Forecast Market, 2016 - 2020; 11.5.3 France Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.5.4 France Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.6. Italy Hematology Drugs Market; 11.6.1. Italy Hematology Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Hematology Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.6.4. Italy Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Hematology Drugs Expenditure, 2012 - 2020; 11.7. Spain Hematology Drugs Market; 11.7.1. Spain Hematology Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Hematology Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 11.7.4. Spain Hematology Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Hematology Drugs Market;
12.1.1. Eastern Europe Hematology Drugs Market Overview; 12.1.2. Eastern Europe Hematology Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Hematology Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 12.2. Eastern Europe Hematology Drugs Market: Country Analysis; 12.3. Russia Hematology Drugs Market; 12.3.1. Russia Hematology Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Hematology Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 12.3.4. Russia Hematology Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
13. North America Hematology Drugs Market;
13.1.1. North America Hematology Drugs Market Overview; 13.1.2. North America Hematology Drugs Historic Market, 2012 - 2016; 13.1.3. North America Hematology Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 13.2. North America Hematology Drugs Market: Country Analysis; 13.3. USA Hematology Drugs Market; 13.3.1. USA Hematology Drugs Historic Market, 2012 - 2016; 13.3.2. USA Hematology Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 13.3.4. USA Hematology Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
14. South America Hematology Drugs Market;
14.1.1. South America Hematology Drugs Market Overview; 14.1.2. South America Hematology Drugs Historic Market, 2012 - 2016; 14.1.3. South America Hematology Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 14.2. South America Hematology Drugs Market: Country Analysis; 14.3. Brazil Hematology Drugs Market; 14.3. Brazil Hematology Drugs Market; 14.3.1. Brazil Hematology Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Hematology Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs; 14.3.4. Brazil Hematology Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Hematology Drugs Expenditure, 2012 - 2020;
15. Middle East Hematology Drugs Market;
15.1.1. Middle East Hematology Drugs Market Overview; 15.1.2. Middle East Hematology Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Hematology Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs;
16. Africa Hematology Drugs Market;
16.1.1. Africa Hematology Drugs Market Overview; 16.1.2. Africa Hematology Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Hematology Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Hematology Drugs Market, 2016, By Segment; Blood Products; Anemia And Other Blood Disorder Drugs;
17. Hematology Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Baxalta; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Bayer Ag; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Novo Nordisk; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Pfizer Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Biogen Idec; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Hematology Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
